MoneyWorks4Me

Hester Biosciences informs about board meeting

24 Jan 2024 Evaluate
Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 to consider and approve standalone and consolidated unaudited financial results for the quarter and nine months period ended 31 December 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..